Digestive Diseases and Sciences

, Volume 53, Issue 5, pp 1175–1185 | Cite as

Barrett’s Columnar-Lined Oesophagus: Demographic and Lifestyle Associations and Adenocarcinoma Risk

  • P. A. C. Gatenby
  • C. P. J. Caygill
  • J. R. Ramus
  • A. Charlett
  • A. Watson
Original Paper
First Online:
Received:
Accepted:

Abstract

Objectives Lifestyle and demographic risk factors for the development of oesophageal adenocarcinoma developing from columnar-lined oesophagus are not well defined. Methods Demographic and lifestyle factors, endoscopy and histology reports were extracted from 1,761 subjects from seven UK centres. The associations of columnar-lined oesophagus with demographic and lifestyle factors and the development of adenocarcinoma were examined. Results 5.5% of patients had prevalent adenocarcinoma (more common in males, older patients, patients diagnosed earlier in the cohort and current or recent smokers). Adenocarcinoma incidence was 23 patients in 3,912 years or 0.59% per annum. Only increased age at diagnosis correlated with an increased risk of incident adenocarcinoma. There was no association with obesity or alcohol history. Conclusions Oesophageal adenocarcinoma occurs more commonly in older patients and is more frequent in males than females. Once columnar-lined oesophagus had been diagnosed, there were no other demographic or lifestyle factors which were predictive of the development of incident adenocarcinoma in this cohort.

Keywords

Barrett’s oesophagus Adenocarcinoma Smoking Alcohol consumption Obesity Health behaviour Epidemiology 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

We are indebted to the registrants and registering centres (see Appendix 1) who made this study possible and to Dr. R. Fitzgerald for assistance in the project design and manuscript preparation. We are grateful to the following for financial support: the Barrett’s Oesophagus Foundation, the Wexham Gastrointestinal Trust, the Childwick Trust, the R. L. St. J. Harmsworth Memorial Research Fund and the David and Frederick Barclay Foundation.

References

  1. 1.
    Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543PubMedGoogle Scholar
  2. 2.
    Newnham A, Quinn MJ, Babb P, Kang JY, Majeed A (2003) Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971–1998/1999. Aliment Pharmacol Ther 17:655–664PubMedGoogle Scholar
  3. 3.
    Kocher HM, Linklater K, Patel S, Ellul JPM (2001) Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg 88:1249–1257PubMedGoogle Scholar
  4. 4.
    Powell J, McConkey CC (1992) The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1:265–269PubMedGoogle Scholar
  5. 5.
    Johnston BJ, Reed PI (1991) Changing pattern of oesophageal cancer in a general hospital in the UK. Eur J Cancer Prev 1:23–25PubMedGoogle Scholar
  6. 6.
    McKinney PA, Sharp L, Macfarlane GJ, Muir CS (1995) Oesophageal and gastric cancer in Scotland 1960–90. Br J Cancer 71:411–415PubMedGoogle Scholar
  7. 7.
    Surveillance Epidemiology and End Results (SEER) (2004) SEER Cancer Statistics Review, 1975–2001. Available online at http://seer.cancer.gov/csr/1975_2001/
  8. 8.
    Daly JM, Karnell LH, Menck HR (1996) National Cancer Data Base Report on esophageal carcinoma. Cancer 78:1820–1828PubMedGoogle Scholar
  9. 9.
    Liabeuf A, Faivre J (1997) Time trends in oesophageal cancer incidence in Côte d’Or (France), 1976–93. Eur J Cancer Prev 6:24–30PubMedGoogle Scholar
  10. 10.
    Tuyns AJ (1992) Oesophageal cancer in France and Switzerland: recent time trends. Eur J Cancer Prev 1:275–278PubMedGoogle Scholar
  11. 11.
    Moller H (1992) Incidence of cancer of the oesophagus, cardia and stomach in Denmark. Eur J Cancer Prev 1:159–164PubMedGoogle Scholar
  12. 12.
    Hansen S, Wiig JN, Giercksky KE, Tretli S (1997) Esophageal and gastric carcinoma in Norway 1958–1992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer 71:340–344PubMedGoogle Scholar
  13. 13.
    Bosch A, Frias Z, Caldwell WL (1979) Adenocarcinoma of the esophagus. Cancer 43:1557–1561PubMedGoogle Scholar
  14. 14.
    Puestow CB, Gillesby WJ, Guynn VL (1955) Cancer of the esophagus. AMA Arch Surg 70:662–671PubMedGoogle Scholar
  15. 15.
    Turnbull ADM, Goodner JT (1968) Primary adenocarcinoma of the esophagus. Cancer 22:915–918PubMedGoogle Scholar
  16. 16.
    Webb JN, Busuttil A (1978) Adenocarcinoma of the oesophagus and of the oesophagogastric junction. Br J Surg 65:475–479PubMedGoogle Scholar
  17. 17.
    Gelfand MD, Finley RJ, Nelems B, Inculet R, Evans KG, Fradet G (1992) Transhiatal esophagectomy for carcinoma of the esophagus and cardia. Experience with 160 cases. Arch Surg 127:1164–1167PubMedGoogle Scholar
  18. 18.
    Putnam JB Jr, Suell DM, McMurtrey MJ, Walsh GL, Natarajan G, Roth JA (1994) Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 57:319–325PubMedCrossRefGoogle Scholar
  19. 19.
    Rahamim J, Cham CW (1993) Oesophagogastrectomy for carcinoma of the oesophagus and cardia. Br J Surg 80:1305–1309PubMedGoogle Scholar
  20. 20.
    Chalasani N, Wo JM, Waring JP (1998) Racial differences in the histology, location, and risk factors of esophageal cancer. J Clin Gastroenterol 26:11–13PubMedGoogle Scholar
  21. 21.
    Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049–2053PubMedGoogle Scholar
  22. 22.
    Blot WJ, Devesa SS, Kneiler RW, Fraumeni JF Jr (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289PubMedGoogle Scholar
  23. 23.
    Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow W-H, Rotterdam H, West B, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89:1277–1284PubMedGoogle Scholar
  24. 24.
    Birgisson S, Rice TW, Easley KA, Richter JE (1997) The lack of association between adenocarcinoma of the esophagus and gastric surgery: a retrospective study. Am J Gastroenterol 92:216–221PubMedGoogle Scholar
  25. 25.
    Gray JR, Coldman AJ, MacDonald WC (1992) Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus. Cancer 69:2227–2231PubMedGoogle Scholar
  26. 26.
    El-Serag HB, Mason AC, Petersen N, Key CR (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50:368–372PubMedGoogle Scholar
  27. 27.
    Menke-Pluymers MBE, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW (1993) Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 72:1155–1158PubMedGoogle Scholar
  28. 28.
    Paraf F, Fléjou JF, Pignon JP, Fékété F, Potet F (1995) Surgical pathology of adenocarcinoma arising in Barrett’s esophagus. Analysis of 67 cases. Am J Surg Pathol 19:183–191PubMedGoogle Scholar
  29. 29.
    Kearney DJ, Crump C, Maynard C, Boyko EJ (2003) A case–control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD. Gastrointest Endosc 57:823–829PubMedGoogle Scholar
  30. 30.
    Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4:85–92PubMedGoogle Scholar
  31. 31.
    Rogers EL, Goldkind SF, Iseri OA, Bustin M, Goldkind L, Hamilton SR, Smith RL (1986) Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett’s esophagus. J Clin Gastroenterol 8:613–618PubMedGoogle Scholar
  32. 32.
    Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG, Liff JM, Fraumeni JF Jr, Hop WCJ (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87:104–109PubMedGoogle Scholar
  33. 33.
    Kabat GC, Ng SKC, Wynder EL (1993) Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Cause Control 4:123–132Google Scholar
  34. 34.
    Tavani A, Negri E, Franceschi S, La Vecchia C (1996) Tobacco and other risk factors for oesophageal cancer in alcohol non-drinkers. Eur J Cancer Prev 5:313–318PubMedGoogle Scholar
  35. 35.
    Drewitz DJ, Sampliner RE, Garewal HS (1997) The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92:212–215PubMedGoogle Scholar
  36. 36.
    Lagergren J, Bergström R, Nyren O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883–890PubMedGoogle Scholar
  37. 37.
    Cheng KK, Sharp L, McKinney PA, Logan RFA, Chilvers CED, Cook-Mozaffari P, Ahmned A, Day NE (2000) A case–control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 83:127–132PubMedGoogle Scholar
  38. 38.
    Caygill CPJ, Johnston DA, Lopez M, Johnston BJ, Watson A, Reed PI, Hill MJ (2002) Lifestyle factors and Barrett’s esophagus. Am J Gastroenterol 97:1328–1331PubMedGoogle Scholar
  39. 39.
    Lagergren J, Bergström R, Lindgren A, Nyrén O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831PubMedGoogle Scholar
  40. 40.
    Haggitt RC, Dean PJ (1985) Adenocarcinoma in Barrett’s epithelium. In: Spechler SJ, Goyal RK (eds) Barrett’s esophagus: pathophysiology, diagnosis, and management. Elsevier, New York, pp 153–166Google Scholar
  41. 41.
    Reid BJ, Weinstein WM (1987) Barrett’s esophagus and adenocarcinoma. Annu Rev Med 38:477–492PubMedGoogle Scholar
  42. 42.
    Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS (2000) Predictors of progression to cancer in Barrett’s esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95:1669–1676PubMedGoogle Scholar
  43. 43.
    Haggitt RC, Tryzelaar J, Dean PJ, Ellis FH, Colcher H (1978) Adenocarcinoma complicating columnar epithelium-lined (Barrett’s) esophagus. Am J Clin Pathol 70:1–5PubMedGoogle Scholar
  44. 44.
    Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR (1983) Barrett’ esophagus. Comparison of benign and malignant cases. Ann Surg 198:554–565PubMedGoogle Scholar
  45. 45.
    Smith RRL, Hamilton SR, Boitnott JK, Rogers EL (1984) The spectrum of carcinoma arising in Barrett’s esophagus. A clinicopathologic study of 26 patients. Am J Surg Pathol 8:563–573PubMedGoogle Scholar
  46. 46.
    Rosenberg JC, Budev H, Edwards RC, Singal S, Steiger Z, Sundareson AS (1985) Analysis of adenocarcinoma in Barrett’s esophagus utilizing a staging system. Cancer 55:1353–1360PubMedGoogle Scholar
  47. 47.
    Rubio CA, Aberg B (1991) Barrett’s mucosa in conjunction with squamous carcinoma of the esophagus. Cancer 68:583–586PubMedGoogle Scholar
  48. 48.
    Watson A (2003) Diagnosis and therapy for advanced esophageal cancer. Curr Opin Gastroenterol 19:400–405PubMedGoogle Scholar
  49. 49.
    Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB (1995) Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 76:1120–1125PubMedGoogle Scholar
  50. 50.
    Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520–531PubMedGoogle Scholar
  51. 51.
    Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA (1990) Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterol 99:918–922Google Scholar
  52. 52.
    Caygill CPJ, Reed PI, Johnston BJ, Hill MJ, Ali MH, Levi S (1999) A single centre’s 20 years’ experience of columnar-lined (Barrett’s) oesophagus diagnosis. Eur J Gastroenterol Hepatol 11:1355–1358PubMedGoogle Scholar
  53. 53.
    Caygill CPJ, Reed PI, McIntyre A, Hill MJ (1998) The UK National Barrett’s Oesophagus Registry: a study between two centres. Eur J Cancer Prev 7:161–164PubMedGoogle Scholar
  54. 54.
    Prach AT, MacDonald TA, Hopwood DA, Johnson DA (1997) Increasing incidence of Barrett’s oesophagus: education, enthusiasm, or epidemiology? Lancet 350:933PubMedGoogle Scholar
  55. 55.
    Carton E, Caldwell MTP, McDonald G, Rama D, Tanner WA, Reynolds JV (2000) Specialized intestinal metaplasia in patients with gastro-oesophageal reflux disease. Br J Surg 87:116–121PubMedGoogle Scholar
  56. 56.
    Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF III, Johnson DA, Creuss DF, Cotelingham JD, Gurney MS, Cattau EL Jr (1987) Barrett’s esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterol 92:118–124Google Scholar
  57. 57.
    Mann NS, Tsai MF, Nair PK (1989) Barrett’s esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 84:1494–1496PubMedGoogle Scholar
  58. 58.
    Gerson LB, Shetler K, Triadafilopoulos G (2002) Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterol 123:461–467Google Scholar
  59. 59.
    Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH (1999) Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterol 116:277–285Google Scholar
  60. 60.
    Gruppo Operativo per lo Studio delle Precancerosi dell ‘Esophago (GOSPE) (1991) Barrett’s esophagus: epidemiological and clinical results of a multicentric study. Int J Cancer 48:364–368Google Scholar
  61. 61.
    Naef AP, Savary M, Ozzello L (1975) Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett’s esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 70:826–835PubMedGoogle Scholar
  62. 62.
    Cooper BT, Barbezat GO (1987) Barrett’s oesophagus: a clinical study of 52 patients. Q J Med 62:97–108PubMedGoogle Scholar
  63. 63.
    Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S (1997) Short segment Barrett’s oesophagus: prevalence, diagnosis and associations. Gut 40:710–715PubMedCrossRefGoogle Scholar
  64. 64.
    Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agréus L (2005) Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterol 129:1825–1831Google Scholar
  65. 65.
    Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, Dunne D, Rahmani EY, Helper DJ (2003) Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterol 125:1670–1677Google Scholar
  66. 66.
    Ward EM, Wolfsen HC, Achem SR, Loeb DS, Krishna M, Hemminger LL, DeVault KR (2006) Barrett’s esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 101:12–17PubMedGoogle Scholar
  67. 67.
    van der Burgh A, Dees J, Hop WCJ, van Blankenstein M (1996) Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut 39:5–8PubMedGoogle Scholar
  68. 68.
    Macdonald CE, Wicks AC, Playford RJ (2000) Final results from 10 year cohort of patients undergoing surveillance for Barrett’s oesophagus: observational study. BMJ 321:1252–1255PubMedGoogle Scholar
  69. 69.
    Anderson LA, Murray LJ, Murphy SJ, Fitzpatrick DA, Johnston BT, Watson RGP, McCarron P, Gavin AT (2003) Mortality in Barrett’s oesophagus: results from a population based study. Gut 52:1081–1084PubMedGoogle Scholar
  70. 70.
    Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ (2002) Hiatal hernia size, Barrett’s length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 97:1930–1936PubMedGoogle Scholar
  71. 71.
    Nilsson J, Skobe V, Johansson J, Willén R, Johnsson F (2000) Screening for oesophageal adenocarcinoma: an evaluation of a surveillance program for columnar metaplasia of the oesophagus. Scand J Gastroenterol 35:10–16PubMedGoogle Scholar
  72. 72.
    O’Connor JB, Falk GW, Richter JE (1999) The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: Report on the Cleveland Clinic Barrett’s Esophagus Registry. Am J Gastroenterol 94:2037–2042PubMedGoogle Scholar
  73. 73.
    van der Veen AH, Blankenstein JD, van Blankenstein M (1989) Adenocarcinoma in Barrett’s oesophagus: an overrated risk. Gut 30:14–18PubMedGoogle Scholar
  74. 74.
    Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ (2000) Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 132:612–620PubMedGoogle Scholar
  75. 75.
    Sampliner RE; The Practice Parameters Committee of the American College of Gastroenterology (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 97:1888–1895PubMedGoogle Scholar
  76. 76.
    Bartelsman JFWM, Hameeteman W, Tytgat GN (1992) Barrett’s oesophagus. Eur J Cancer Prev 1:323–325Google Scholar
  77. 77.
    Williamson WA, Ellis FH Jr, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, Watkins E Jr (1991) Barrett’s esophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 151:2212–2216PubMedGoogle Scholar
  78. 78.
    Miros M, Kerlin P, Walker N (1991) Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus. Gut 32:1441–1446PubMedGoogle Scholar
  79. 79.
    Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR (2000) The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol 95:3383–3387PubMedGoogle Scholar
  80. 80.
    Pellegrini CA, Pohl D (2000) High-grade dysplasia in Barrett’s esophagus: surveillance or operation? J Gastrointest Surg 4:131–134PubMedGoogle Scholar
  81. 81.
    Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnaduth KK, Lutzke LS, Anderson MA, Petterson TM, Bugart LJ (2001) Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterol 120:1630–1639Google Scholar
  82. 82.
    Gerson LB, Triadafilopoulos G (2002) Screening for esophageal adenocarcinoma: an evidence-based approach. Am J Med 113:499–505PubMedGoogle Scholar
  83. 83.
    Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ (1993) An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterol 105:40–50Google Scholar
  84. 84.
    Fitzgerald RC, Saeed IT, Khoo D, Farthing MJG, Burnham WR (2001) Rigorous surveillance protocol increases detection of curable cancers associated with Barrett’s esophagus. Dig Dis Sci 46:1892–1898PubMedGoogle Scholar
  85. 85.
    Peters JH, Clark GWR, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR (1994) Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108:813–821PubMedGoogle Scholar
  86. 86.
    van Sandick JW, van Lanschott JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H (1998) Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut 43:216–222PubMedCrossRefGoogle Scholar
  87. 87.
    Fountoulakis A, Zafirellis KD, Dolan K, Dexter SPL, Martin IG, Sue-Ling HM (2004) Effect of surveillance of Barrett’s oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 91:997–1003PubMedGoogle Scholar
  88. 88.
    Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA (2002) Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterol 122:633–640Google Scholar
  89. 89.
    Ferguson MK, Durkin A (2002) Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 6:29–36PubMedGoogle Scholar
  90. 90.
    Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L, Ancona E, Peracchia A (1997) Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett’s esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 10:190–195PubMedGoogle Scholar
  91. 91.
    Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, Giudicelli R, Fuentes P (1997) Changing patterns and surgical results in adenocarcinoma of the oesophagus. Br J Surg 84:119–125PubMedGoogle Scholar
  92. 92.
    Stein HJ, Feith M, Mueller J, Werner M, Siewert JR (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 232:733–742PubMedGoogle Scholar
  93. 93.
    Rice TW, Blackstone EH, Goldblum JR, DeCamp MM, Murthy SC, Falk GW, Ormsby AH, Rybicki LA, Richter JE, Adelstein DJ (2001) Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 122:1077–1090PubMedGoogle Scholar
  94. 94.
    Hölscher AH, Bollschweiler E, Bumm R, Bartels H, Höfler H, Siewert JR (1995) Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 118:845–855PubMedGoogle Scholar
  95. 95.
    Lerut T, Coosemans W, van Raemdonck D, Dillemans B, de Leyn P, Marnette JM, Geboes T (1994) Surgical treatment of Barrett’s carcinoma. Correlations between morphological findings and prognosis. J Thorac Cardiovasc Surg 107:1059–1065PubMedGoogle Scholar
  96. 96.
    Rusch VW, Levine DS, Haggitt RC, Reid BJ (1994) The management of high grade dysplasia and early cancer in Barrett’s esophagus. A multidisciplinary problem. Cancer 74:1225–1229PubMedGoogle Scholar
  97. 97.
    Kahaleh M, Van Laethem JL, Nagy N, Cremer M, Deviere J (2002) Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34:950–955PubMedGoogle Scholar
  98. 98.
    Schulz H, Miehlke S, Antos D, Schentke KU, Vieth M, Stolte M, Bayerdörffer E (2000) Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 51:659–663PubMedGoogle Scholar
  99. 99.
    Overholt BF, Panjehpour M, Halberg DL (2003) Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 58:183–188PubMedGoogle Scholar
  100. 100.
    Ell C, May A, Gossner L, Pech O, Günter E, Mayer G, Henrich R, Vieth M, Müller H, Seitz G, Stolte M (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterol 118:670–677Google Scholar
  101. 101.
    Streitz JM, Ellis FH, Tilden RL, Erickson RV (1998) Endoscopic surveillance of Barrett’s esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 93:911–915PubMedCrossRefGoogle Scholar
  102. 102.
    Provenzale D, Schmitt C, Wong JB (1999) Barrett’s esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 94:2043–2053PubMedGoogle Scholar
  103. 103.
    Eloubeidi MA, Homan RK, Martz MD, Theobald KE, Provenzale D (1999) A cost analysis of outpatient care for patients with Barrett’s esophagus in a managed care setting. Am J Gastroenterol 94:2033–2036PubMedGoogle Scholar
  104. 104.
    Nietert PJ, Silverstein MD, Makhashi MS, Kim CY, Glenn TF, Marsi VA, Hawes RH, Wallace MB (2003) Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc 57:311–318PubMedGoogle Scholar
  105. 105.
    Watson A, Heading RC, Shepherd NA (2005) Guidelines for the diagnosis and management of Barrett’s columnar-lined oesophagus. A report of the Working Party of the British Society of Gastroenterology, August 2005. BSG Guidelines in Gastroenterology. Available online at http://www.bsg.org.uk/pdf_word_docs/Barretts_Oes.pdf
  106. 106.
    Watson A (2000) Barrett’s oesophagus—50 years on. Br J Surg 87:529–531PubMedGoogle Scholar
  107. 107.
    Reed PI, Watson A (1996) Notes: UK National Barrett’s Oesophagus Registry. Gut 39:499–500Google Scholar
  108. 108.
    Micoscoft Access (2002) Microsoft Corporation. Home page at http://office.microsoft.com/en-gb/access/default.aspx
  109. 109.
    Report by the Comptroller and Auditor General (2001) Tackling obesity in England. National Audit Office (NAO). Available online at http://www.nao.org.uk/publications/nao_reports/00-01/0001220.pdf
  110. 110.
    Solaymani-Dodaran M, Logan RFA, West J, Card T, Coupland C (2004) Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. Gut 53:1070–1074PubMedGoogle Scholar
  111. 111.
    Iftikar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M (1992) Length of Barrett’s oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33:1155–1158Google Scholar
  112. 112.
    Murray L, Watson P, Johnston B, Sloan J, Mainie IML, Gavin A (2003) Risk of adenocarcinoma in Barrett’s oesophagus: population based study. BMJ 327:534–535PubMedGoogle Scholar
  113. 113.
    Cameron AJ, Lomboy CT (1992) Barrett’s esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterol 103:1241–1245Google Scholar
  114. 114.
    Schoenfeld P, Johnston M, Piorkowski M, Jones DM, Eloubeidi MA, Provenzale D (1998) Effectiveness and patient satisfaction with nurse-directed treatment of Barrett’s esophagus. Am J Gastroenterol 93:906–910PubMedGoogle Scholar
  115. 115.
    Hofsetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, Tsai P, Banki F, Bremner CG (2001) Long-term outcome of antireflux surgery in patients with Barrett’s esophagus. Ann Surg 234:532–539Google Scholar
  116. 116.
    Weston AP, Badr AS, Hassanein RS (1999) Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94:3413–3419PubMedGoogle Scholar
  117. 117.
    Cameron AJ, Ott BJ, Payne WS (1985) The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 313:857–859PubMedCrossRefGoogle Scholar
  118. 118.
    Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D (1998) The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 93:536–541PubMedGoogle Scholar
  119. 119.
    Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE (1997) Dysplasia in short-segment Barrett’s esophagus: a prospective 3-year follow-up. Am J Gastroenterol 92:2012–2016PubMedGoogle Scholar
  120. 120.
    Eloubeidi MA, Provenzale D (2001) Clinical and demographic predictors of Barrett’s esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 33:306–309PubMedGoogle Scholar
  121. 121.
    Gerson LB, Ullah N, Fass R, Green C, Shetler K, Singh G (2007) Does body mass index differ between patients with Barrett’s oesophagus and patients with chronic gastro-oesophageal reflux disease? Aliment Pharmacol Ther 25:1079–1086PubMedCrossRefGoogle Scholar
  122. 122.
    Mabrut J-Y, Baulieux J, Adham M, De La Roche E, Gaudin J-L, Souquet J-C, Ducerf C (2003) Impact of antireflux operation on columnar-lined esophagus. J Am Coll Surg 196:60–67PubMedGoogle Scholar
  123. 123.
    Levi F, Ollyo J-B, La Vecchia C, Boyle P, Monnier P, Savary M (1990) The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett’s oesophagus. Int J Cancer 45:852–854PubMedGoogle Scholar
  124. 124.
    Kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, Meyer-Saballek W, Stolte M, Lind T, Malfertheiner P, Willich SN (2004) Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 57:580–589PubMedGoogle Scholar
  125. 125.
    Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman J-P, Sampliner RE, Schnell TG, Sontag SJ, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338PubMedGoogle Scholar
  126. 126.
    Veuglers PJ, Porter GA, Guernsey DL, Casson AG (2006) Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 19:321–328Google Scholar
  127. 127.
    Avidan B, Sonnenberg A, Schnell TG, Sontag SJ (2002) There are no reliable symptoms for erosive oesophagitis and Barrett’s oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther 16:735–742PubMedGoogle Scholar
  128. 128.
    Gray MR, Donnelly RJ, Kingsnorth AN (1993) The role of smoking and alcohol in metaplasia and cancer risk in Barrett’s columnar lined oesophagus. Gut 34:727–731PubMedGoogle Scholar
  129. 129.
    Reid BJ, Blount PL, Feng Z, Levine DS (2000) Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol 95:3089–3096PubMedGoogle Scholar
  130. 130.
    Reid BJ, Haggitt RC, Rubin CE, Roth C, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H (1988) Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 19:166–178PubMedGoogle Scholar
  131. 131.
    Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47:251–255PubMedGoogle Scholar
  132. 132.
    Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K (2001) Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32:368–378PubMedGoogle Scholar
  133. 133.
    Ormsby AH, Petras RE, Henricks WH, Rice TW, Rybicki LA, Richter JE, Goldblum JR (2002) Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 51:671–676PubMedGoogle Scholar
  134. 134.
    Csendes A, Braghetto I, Burdiles P, Puente G, Korn O, Diaz JC, Maluenda F (1998) Long-term results of classic antireflux surgery in 152 patients with Barrett’s esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 123:645–657PubMedGoogle Scholar
  135. 135.
    Ferraris R, Bonelli L, Conio M, Fracchia M, Lapertosa G, Aste H (1997) Incidence of Barrett’s adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Eur J Gastroenterol Hepatol 9:881–885PubMedGoogle Scholar
  136. 136.
    Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG (1989) Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterol 96:1249–1256Google Scholar
  137. 137.
    McDonald ML, Trastek VF, Allen MS, Deschamps C, Pairolero PC (1996) Barrett’s esophagus: does an antireflux procedure reduce the need for endoscopic surveillance. J Thorac Cardiovasc Surg 111:1135–1140PubMedGoogle Scholar
  138. 138.
    Moghissi K, Sharpe DA, Pender D (1993) Adenocarcinoma and Barrett’s oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg 7:126–131PubMedGoogle Scholar
  139. 139.
    Ovaska J, Miettinen M, Kivilaakso E (1989) Adenocarcinoma arising in Barrett’s esophagus. Dig Dis Sci 34:1336–1339PubMedGoogle Scholar
  140. 140.
    Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M (1988) Value of endoscopic surveillance in the detection of neoplastic change in Barrett’s oesophagus. Br J Surg 75:760–763PubMedGoogle Scholar
  141. 141.
    Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, Colton T, Schimmel EM (1984) Adenocarcinoma and Barrett’s esophagus. An overrated risk? Gastroenterol 87:927–933Google Scholar
  142. 142.
    Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, Myskow M, Nash J, Donnelly RJ, Kingsnorth AN (1996) Cost effectiveness of detecting Barrett’s cancer. Gut 39:574–579PubMedGoogle Scholar
  143. 143.
    Eckardt VF, Kanzler G, Bernhard G (2001) Life expectancy and cancer risk in patients with Barrett’s esophagus: a prospective controlled investigation. Am J Med 111:33–37PubMedGoogle Scholar
  144. 144.
    Attwood SE, Barlow AP, Norris TL, Watson A (1992) Barrett’s oesophagus: effect of antireflux surgery on symptom control and development of complications. Br J Surg 79:1050–1053PubMedGoogle Scholar
  145. 145.
    Brand DL, Ylvisaker JT, Gelfand M, Pope CE II (1980) Regression of columnar esophageal (Barrett’s) epithelium after anti-reflux surgery. N Engl J Med 302:844–848PubMedCrossRefGoogle Scholar
  146. 146.
    Oelschlager BK, Barreca M, Chang L, Oleynikov D, Pellegrini CA (2003) Clinical and pathologic response of Barrett’s esophagus to laparoscopic antireflux surgery. Ann Surg 238:458–466PubMedGoogle Scholar
  147. 147.
    Parrilla P, Martinez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 237:291–298PubMedGoogle Scholar
  148. 148.
    Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN (1995) Regression and progression of Barrett’s oesophagus after antireflux surgery. Br J Surg 82:806–810PubMedGoogle Scholar
  149. 149.
    Bani-Hani K, Sue-Ling HM, Johnston D, Axon AT, Martin IG (2000) Barrett’s oesophagus: results from a 13-year surveillance programme. Eur J Gastroenterol Hepatol 12:649–654PubMedGoogle Scholar
  150. 150.
    Polepalle SC, McCallum RW (1990) Barrett’s esophagus. Current assessment and future perspectives. Gastroenterol Clin North Am 19:733–744PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • P. A. C. Gatenby
    • 1
  • C. P. J. Caygill
    • 1
  • J. R. Ramus
    • 1
  • A. Charlett
    • 2
  • A. Watson
    • 1
  1. 1.UK National Barrett’s Oesophagus Registry (UKBOR)Royal Free and University College Medical SchoolLondonUK
  2. 2.Health Protection AgencyLondonUK

Personalised recommendations